AAAAAA

   
Results: 1-11 |
Results: 11
Regulation of prostate-specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone-releasing hormoneand vasoactive intestinal peptide
Authors: Rekasi, Z Schally, AV Plonowski, A Czompoly, T Csernus, B Varga, JL
Citation: Z. Rekasi et al., Regulation of prostate-specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone-releasing hormoneand vasoactive intestinal peptide, PROSTATE, 48(3), 2001, pp. 188-199
Antiproliferative actions of growth hormone-releasing hormone antagonists on MiaPaCa-2 human pancreatic cancer cells involve cAMP independent pathways
Authors: Rekasi, Z Varga, JL Schally, AV Plonowski, A Halmos, G Csernus, B Armatis, P Groot, K
Citation: Z. Rekasi et al., Antiproliferative actions of growth hormone-releasing hormone antagonists on MiaPaCa-2 human pancreatic cancer cells involve cAMP independent pathways, PEPTIDES, 22(6), 2001, pp. 879-886
Luteinizing hormone-releasing hormone (LH-RH) antagonist Cetrorelix down-regulates the mRNA expression of pituitary receptors for LH-RH by counteracting the stimulatory effect of endogenous LH-RH
Authors: Kovacs, M Schally, AV Csernus, B Rekasi, Z
Citation: M. Kovacs et al., Luteinizing hormone-releasing hormone (LH-RH) antagonist Cetrorelix down-regulates the mRNA expression of pituitary receptors for LH-RH by counteracting the stimulatory effect of endogenous LH-RH, P NAS US, 98(4), 2001, pp. 1829-1834
Peptide analogs in the therapy of prostate cancer
Authors: Schally, AV Comaru-Schally, AM Plonowski, A Nagy, A Halmos, G Rekasi, Z
Citation: Av. Schally et al., Peptide analogs in the therapy of prostate cancer, PROSTATE, 45(2), 2000, pp. 158-166
Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways
Authors: Plonowski, A Schally, AV Varga, JL Rekasi, Z Hebert, F Halmos, G Groot, K
Citation: A. Plonowski et al., Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways, PROSTATE, 44(2), 2000, pp. 172-180
Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice
Authors: Kahan, Z Varga, JL Schally, AV Rekasi, Z Armatis, P Chatzistamou, I Czompoly, T Halmos, G
Citation: Z. Kahan et al., Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice, BREAST CANC, 60(1), 2000, pp. 71-79
Antagonistic actions of analogs related to growth hormone-releasing hormone (GHRH) on receptors for GHRH and vasoactive intestinal peptide on rat pituitary and pineal cells in vitro
Authors: Rekasi, Z Varga, JL Schally, AV Halmos, G Groot, K Czompoly, T
Citation: Z. Rekasi et al., Antagonistic actions of analogs related to growth hormone-releasing hormone (GHRH) on receptors for GHRH and vasoactive intestinal peptide on rat pituitary and pineal cells in vitro, P NAS US, 97(3), 2000, pp. 1218-1223
Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone
Authors: Halmos, G Schally, AV Varga, JL Plonowski, A Rekasi, Z Czompoly, T
Citation: G. Halmos et al., Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone, P NAS US, 97(19), 2000, pp. 10555-10560
Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers
Authors: Rekasi, Z Czompoly, T Schally, AV Halmos, G
Citation: Z. Rekasi et al., Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers, P NAS US, 97(19), 2000, pp. 10561-10566
Antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide inhibit tumor proliferation by different mechanisms: Evidence from in vitro studies on human prostatic and pancreatic cancer
Authors: Rekasi, Z Varga, JL Schally, AV Halmos, G Armatis, P Groot, K Czompoly, T
Citation: Z. Rekasi et al., Antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide inhibit tumor proliferation by different mechanisms: Evidence from in vitro studies on human prostatic and pancreatic cancer, ENDOCRINOL, 141(6), 2000, pp. 2120-2128
Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities
Authors: Varga, JL Schally, AV Csernus, VJ Zarandi, M Halmos, G Groot, K Rekasi, Z
Citation: Jl. Varga et al., Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities, P NAS US, 96(2), 1999, pp. 692-697
Risultati: 1-11 |